Hong Kong lacks official strategy on viral hepatitis, study finds
City found to be only one among 13 Asia-Pacific territories surveyed to be without government-led policy to eradicate disease
A study by a Hong Kong university has found that the city’s government lags behind other Asia-Pacific jurisdictions in terms of preventing and treating chronic viral hepatitis – linked to liver cancer.
Chinese University researchers surveyed 13 territories across the region, including Australia, Bangladesh, and China. Of these, Hong Kong was the only one lacking a government-led strategy to eliminate viral hepatitis.
Nearly one in every 10 Hong Kong residents is infected with chronic hepatitis B, according to the study, released on Wednesday.
Instead of a strategic official plan, Hong Kong follows the more general Asia-Pacific regional guidelines on hepatitis management.
“We’re hoping that the new government will look into this problem,” said Professor Joseph Sung Jao-yiu, the university’s president and vice-chancellor, and a founding member of the Coalition to Eradicate Viral Hepatitis in Asia Pacific.
The viral disease kills more than 1.34 million people worldwide each year. Many of those carrying hepatitis live in the Asia-Pacific region and South Asia.